Bunnage Mark E. (CIK 2100735) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-19). Recent activity: Sell VRTX (33 shares), Sell VRTX (582 shares), Sell VRTX (620 shares), Buy VRTX (2,584 shares), Sell VRTX (1,110 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 33 | $14,964 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 582 | $282,334 |
| 2026-02-26 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 620 | $301,537 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Buy | 2,584 | $0 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 1,110 | $536,962 |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 2,437 | $1.2M |
| 2026-02-19 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 1,182 | $559,890 |
| 2026-02-18 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 2,283 | $1.1M |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 1,127 | $527,898 |
| 2026-02-12 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | EVP, Chief Scientific Officer | Sell | 2,021 | $930,529 |
Source: SEC Form 4 filings · as of 2026-05-19